![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.675 | 1.65 | 1.70 | 1.725 | 1.625 | 1.68 | 14,710,507 | 08:49:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.76 | 9.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2021 07:12 | Gibso6767, what utter rubbish.It may mirror NCYT but needs revenue to do that which is very likely to be good dealing with BC.I have not seen ANYONE say it can rise that well without it. | hooded claw | |
15/2/2021 07:06 | ODX directors cashing in .... | ![]() amaretto1 | |
14/2/2021 20:07 | There are not that many shares in issue so my concern is that many believe that this may mirror and eclipse Novacyt but just by buying alone rather than numbers to underpin a share price. Hoping for more institutional buyers | ![]() gibso6767 | |
14/2/2021 19:31 | Hazl, are you French?. | ![]() thehitman1 | |
14/2/2021 18:53 | Expecting FDA announcement this week | ![]() swerves1 | |
14/2/2021 18:09 | Yes for years, and a capacity to quickly deploy a test for new variants, or completely new viruses will be needed, along with the commercial vehicle to quickly convert a testing solution to testing capability. | hodhasharon | |
14/2/2021 17:56 | There will be the need for these tests for years I agree. | ![]() hazl | |
14/2/2021 17:41 | Red hot sector and people selling on a slight pullback and whim, minimum £4 to start with, look at ncyt to see what can be achieved | ![]() milliecusto | |
14/2/2021 14:47 | “I wouldn't be taking much notice of posters comments about 300-350” Why? Most of the figures professionally produced at circa 500-550p are based on capacity, demand, and varying degrees of profit per test. Some of the comments on here suggest you don’t know the business you’re invested in, or the magnitude of the recent partnerships. The large players will take your shares from you at a discount because they know you’ll question your own investment at the slightest of pullbacks or shakes. | hodhasharon | |
14/2/2021 14:03 | Nicely said ! Yes that makes sense. I have done a lot of research on this and I agree the 300 350 mark is of limits but 200 certainly achievable. Bough in again at 125 so looking for the 170 and be happy to sell again. Certainly hope it's hits that mark :) | ![]() rayj1 | |
14/2/2021 13:09 | Rayj1, In relation to your earlier post i can see exactly where you are coming from. My own experience here is that GDR were on my watchlist and when they started climbing rapidly from under 50c at the end of Jan i paid closer attention and eventually bought in at 70. Obviously i consider these a high risk stock so once they reached 151 i took out my initial investment. I still think these have farther to go but would be interested in the next RNS and agree that from here its all about sales. In the short term i wouldn't be taking much notice of posters comments about 300-350 etc But would be very happy to hit 200 myself and then review again. As Hazl says this is a very attractive sector at the moment and there are other companies to consider as well so i am spreading my risk FAB and BRH are 2 examples worth looking at. Always be happy to take profits and never risk too much on shares with "potential" and always do your own research. All IMHO | ![]() krutt | |
14/2/2021 12:53 | I like the seeming honesty that has developed in this board. 4777 Pugugly. I am in exactly the same position and a good post. | ![]() hazl | |
14/2/2021 12:43 | cut and paste merchant !!! | m0riarty | |
14/2/2021 12:41 | Ha I wondered. Thanks. | ![]() hazl | |
14/2/2021 12:40 | Reference to earlier post. 'Hepatitis C is a virus that can infect the liver. If left untreated, it can sometimes cause serious and potentially life-threatening damage to the liver over many years. But with modern treatments, it's usually possible to cure the infection, and most people with it will have a normal life expectancy. It's estimated around 215,000 people in the UK have hepatitis C.' NHS | ![]() hazl | |
14/2/2021 12:38 | Gold ore. From the Gadir mine in Azerbaijan. :) Video | jbravo2 | |
14/2/2021 12:16 | Jbravo what are you holding in your profile picture? 8-) | ![]() hazl | |
14/2/2021 12:13 | You're welcome. Take care. | ![]() hazl | |
14/2/2021 11:17 | Thank you makes sense. I am not new. We but not as experienced as many on here. So thank you :) | ![]() rayj1 | |
14/2/2021 10:27 | U can have every make of Car on a Car lot .....If you don't sell one ... u can't pay the rent !!! | ![]() amaretto1 | |
14/2/2021 10:23 | Did you know that genedrive is involved with detection of HVC? See above. This is a horrible disease and can really help people if it is found early. | ![]() hazl | |
14/2/2021 10:15 | Eh ? .... the market cap has doubled !! | ![]() amaretto1 | |
14/2/2021 10:12 | Only sentiment drives the in either direction, nothing more. | ![]() countdracula55 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions